GABA A receptors (GABA A Rs) are the major mediators of fast synaptic inhibition in the brain. In neurons, these receptors undergo significant rates of endocytosis and exocytosis, processes that regulate both their accumulation at synaptic sites and the efficacy of synaptic inhibition. Here we have evaluated the role that neuronal activity plays in regulating the residence time of GABA A Rs on the plasma membrane and their targeting to synapses. Chronic blockade of neuronal activity dramatically increases the level of the GABA A R ubiquitination, decreasing their cell surface stability via a mechanism dependent on the activity of the proteasome. Coincident with this loss of cell surface expression levels, TTX treatment reduced both the amplitude and frequency of miniature inhibitory synaptic currents. Conversely, increasing the level of neuronal activity decreases GABA A R ubiquitination enhancing their stability on the plasma membrane. Activity-dependent ubiquitination primarily acts to reduce GABA A R stability within the endoplasmic reticulum and, thereby, their insertion into the plasma membrane and subsequent accumulation at synaptic sites. Thus, activity-dependent ubiquitination of GABA A Rs and their subsequent proteasomal degradation may represent a potent mechanism to regulate the efficacy of synaptic inhibition and may also contribute to homeostatic synaptic plasticity.
Introduction
GABA A receptors (GABA A Rs), mediate the majority of fast synaptic inhibition in the brain and also represent the major sites of action for both benzodiazepines and barbiturates. These receptors are Cl Ϫ -selective ligand-gated ion channels that can be assembled from seven subunit classes: ␣1-␣6, ␤1-␤3, ␥1-␥3, ␦, , and , providing the structural basis for extensive heterogeneity of GABA A R structure (Sieghart and Sperk, 2002; Mohler, 2004, 2006) . A combination of molecular, biochemical, and genetic approaches suggest that, in the brain, the majority of benzodiazepine receptor subtypes are composed of ␣, ␤, and ␥2 subunits (Rudolph and Mohler, 2004) . ␥2-containing receptors are highly enriched at synaptic sites in neurons and are responsible for mediating phasic inhibition (Essrich et al., 1998; Kittler and Moss, 2003; Luscher and Keller, 2004) .
The number of GABA A Rs on the neuronal cell surface is a critical determinant for the efficacy of synaptic inhibition, and, at steady state, this is determined by the rates of receptor insertion and removal from the plasma membrane. It is evident that GABA A Rs are assembled within the endoplasmic reticulum (ER) and then transported to the plasma membrane for insertion, whereas misfolded or unassembled receptor subunits are rapidly targeted for ER-associated degradation (Gorrie et al., 1997; Kittler and Moss, 2003; Luscher and Keller, 2004) . Degradation of ER-retained GABA A Rs is mediated via the activity of the proteasome and is subject to modulation via their association with the ubiquitin-like protein Plic-1 (Bedford et al., 2001) . Cell surface GABA A Rs are dynamic entities that exhibit rapid rates of constitutive endocytosis, with internalized receptors being subject to rapid recycling or lysosomal degradation (Kittler and Moss, 2003; Luscher and Keller, 2004; Kittler et al., 2005) . Intriguingly, a number of studies have provided evidence that chronic changes in neuronal activity can modulate inhibitory neurotransmission by regulating both presynaptic components in addition to modifying postsynaptic GABA A R levels (Rutherford et al., 1997; Kilman et al., 2002; Hartman et al., 2006) . The mechanisms underlying this homeostatic modulation of GABA A R functional expression remain ill defined.
Here we have addressed the role that neuronal activity plays in regulating GABA A R turnover and membrane trafficking and the subsequent accumulation of these proteins on the neuronal plasma membrane. Our results demonstrate that the level of neuronal activity can regulate the ubiquitination of GABA A Rs in the secretory pathway enhancing their degradation primarily within the ER and thereby altering the efficacy of synaptic inhibition. This process decreases the number of receptors inserted into the plasma membrane and their subsequent accumulation at inhib-sampled at 5 kHz, digitized (Digidata 1320A; Molecular Devices), and stored for off-line analysis [using Minianalysis (Synaptosoft, Decatur GA) and IGOR Pro (WaveMetrics, Lake Oswego, OR)]. Access resistance (10 -18 M⍀; 80% compensation) was monitored using a Ϫ5 mV voltage, applied every 120 s, and data from cells were discarded when Ͼ15% change occurred. Miniature events were analyzed using pClamp 9.2 (Clampfit; Molecular Devices) and MiniAnalysis 6.0.3 software (Synaptosoft, Leonia, NJ) using pooled population data from expressed as mean Ϯ SEM. An individual event was defined as being Ͼ2.5 SDs from the average background noise. The decay phase was fitted with a monoexponential function ( decay). Rise time was also analyzed by comparing the mean 10 -90% rise time.
Immunofluorescence. Transfected neurons were fixed in 4% paraformaldehyde, stained without membrane permeabilization with rabbit anti-GFP, and then permeabilized with 0.1% Triton X-100 for 4 min. They were then labeled with anti-synapsin antibodies, visualized by confocal microscopy (blind to experimental condition), and analyzed using MetaMorph (Molecular Devices) software. Receptor clusters were defined as being ϳ0.5-2 m in length and approximately twofold to threefold more intense than background diffuse fluorescence and were colocalized with or directly apposed to synapsin staining. Clusters farther than 1 m from presynaptic marker staining were considered extrasynaptic. To quantify the number of synapses, thresholds were set and kept constant for control and test neurons. To measure the role of ubiquitination in regulating GABA A R membrane insertion, we used ␤3 and ␤3 K12R expression constructs modified at the N terminus with a pHluorin reporter and the minimal ␣-bungarotoxin (Bgt) binding site peptide (BBS). These are termed BBS ␤3 and BBS ␤3 K12R , respectively (Scherf et al., 2001; Katchalski-Katzir et al., 2003; Sekine-Aizawa and Huganir, 2004; Bogdanov et al., 2006) . BBS ␤3 synaptic puncta were counted from 1-bit binary masks. Data were analyzed from 15-20 neurons for each condition (50 m per dendrite per cell). To quantify fluorescence intensity of BBS ␤3 synaptic staining, images of neurons were thresholded to a point at which dendrites were outlined. Synapsin staining was thresholded to a set value and kept constant for control and test neurons. Next a 50 m section along a given proximal dendrite was selected, and a 1-bit binary image (exclusive) was made of the synapsin staining in the outlined dendrite. We then subtracted away all BBS ␤3 staining that did not colocalize with the binarized synapsin staining. As a result, only BBS ␤3 staining that colocalized with synapsin remained, and the average fluorescence intensity of these BBS ␤3puncta was determined. Data were analyzed from 15-20 neurons for each condition from at least two to three different cultures. Finally, puncta selection and analysis were all performed blind to experimental condition.
Immunoprecipitation. HEK-293 cells or neurons were lysed in 1% SDS, 25 mM Tris, pH 7.4. Lysates were diluted 10-fold with RIPA buffer lacking SDS: 50 mM Tris, pH 8, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 2 mM EDTA plus 1 M ubiquitin aldehyde (Biomol), and mammalian protease inhibitor cocktail (Sigma-Aldrich). After correction for protein content, lysates were immunoprecipitated with rabbit anti-myc IgGs (Santa Cruz Biotechnology) or anti-␤3 antibodies as detailed previously (Brandon et al., 2000 (Brandon et al., , 2001 Jovanovic et al., 2004; Kittler et al., 2004) . Precipitated material was then subject to SDS-PAGE and immunoblotting.
Membrane insertion assays. HEK-293 cells expressing GABA A R ␣1 and BBS ␤3 subunits were incubated with 10 g/ml unlabeled ␣-Bgt for 20 min at 4°C (to inhibit endocytosis), washed in PBS, and incubated with 10 g/ml biotin-conjugated Bgt at 37°C for up to 20 min to label newly inserted receptors. After lysis, biotin-Bgt/ BBS ␤3 complexes were purified on neutravidin and immunoblotted with anti-␤3 antibodies. To measure insertion in neurons nucleofected 15 DIV hippocampal cultures were labeled at 37°C with 10 g/ml rhodamine (Rd)-conjugated Bgt for 15 min, washed, and incubated for an additional 5 min with 10 g/ml Alexa-Fluor-647 (Alx)-conjugated Bgt. All incubations were performed in the presence of 5 M tubocurarine (Sigma-Aldrich) to block Bgt binding to endogenous acetylcholine receptors (Sekine-Aizawa and Huganir, 2004; Bogdanov et al., 2006) . All Bgt derivatives were obtained from Invitrogen (Carlsbad, CA). Cells were fixed in 4% paraformaldehyde, and confocal images were collected using a 60ϫ objective lens acquired with Olympus Optical (Tokyo, Japan) Fluoview version 1.5 software, and the same image acquisition settings for BBS ␤3 and BBS ␤3 K12R (Bogdanov et al., 2006) were used. These images were analyzed using MetaMorph imaging software (Universal Imaging, Downingtown, PA). First, a threedimensional reconstruction of an imaged neuron was made from a series of Z sections, and then the average fluorescence intensity of Alexa-Fluor-647-Bgt staining per 250 m of dendrite was measured from three dendrites per neuron, after subtraction of background fluorescence.
Mutagenesis. Site-directed mutagenesis of the ␤3 subunit was performed using the QuickChange mutagenesis kit (Stratagene, La Jolla, CA).
Statistical analysis. Statistical significance was assessed using either Student's paired t test or the Kolmogorov-Smirnov two-sample test, in which p Ͻ 0.05 was considered significant.
Results
Chronic changes in neuronal activity regulate the numbers of GABA A R expressed on the neuronal cell surface To commence our studies, we used cultured cortical neurons that had been maintained for at least 14 d DIV and have been demonstrated to exhibit hyperpolarizing GABA A R responses (Woodin et al., 2003; Fiumelli et al., 2005) . The effects of the voltage-gated Na ϩ channel blocker TTX on the number of cell surface GABA A Rs containing ␤3 subunits was then examined. After cell lysis and correction for protein content, biotinylated proteins were purified on avidin and immunoblotted with antibodies specific to the ␤3 subunit (Jovanovic et al., 2004; Kittler et al., 2004) . We chose to study primarily GABA A R subtypes containing ␤3 subunits because gene knock-out has revealed that these proteins are critical for neuronal function and animal survival (Homanics et al., 1997) . Treatment of cultures with 2 M TTX for 24 h resulted in a significant decrease (to 47.8 Ϯ 5.3% of control) (Fig.  1 A) in cell surface levels of GABA A Rs containing ␤3 subunits. The total expression of receptor ␤3 subunits was also reduced by this treatment (to 45 Ϯ 6.7% of control) (Fig. 1 A) . Similar statistically significant decreases in the cell surface expression levels of GABA A R ␣2 and ␥2 subunits were also evident (supplemental Fig. 1 , available at www.jneurosci.org as supplemental material), suggesting that chronic neuronal inactivity leads to the loss of functional heteromeric cell surface GABA A Rs. In addition TTX treatment also significantly decreased the number of cell surface GABA A Rs containing ␤3 subunits in 16 DIV hippocampal neurons (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material).
To corroborate our experiments with TTX, we assessed the effects of blocking excitatory synaptic transmission on the cell surface levels of GABA A Rs with glutamate receptor antagonists, which have been established to reduce neuronal activity in culture (Rao and Craig, 1997; O'Brien et al., 1998) . Blockade of glutamate receptors significantly decreased the cell surface expression levels of GABA A Rs containing ␤3 subunits to 45.8 Ϯ 13.1% of control (Fig. 1 B) . We also examined the effects of chronically increasing neuronal activity on the cell surface expression levels of GABA A Rs using picrotoxin (PTX) (40 M), a GABA A R antagonist and has been shown to increase the activity of neuronal cultures (Rao and Craig, 1997; O'Brien et al., 1998) . In contrast to the effects of TTX and glutamate receptor antagonists, treatment of neurons with PTX significantly increased both the cell surface (by 55 Ϯ 2.3% of control) and total (by 47 Ϯ 8.5% of control) expression levels of the GABA A Rs ␤3 subunit (Fig. 1C) .
To assess whether the reduced levels of cell surface GABA A Rs evident with TTX alters synaptic inhibition we compared the properties of mIPSCs in hippocampal neurons (Ͼ16 DIV) treated with or without TTX. mIPSCs were isolated by adding the excitatory amino acid antagonists (10 M CNQX, 20 M D-AP-5) and TTX (2 M) to the bath solution as described previously Chen et al., 2006) . Under these conditions remaining events were blocked by picrotoxin (20 M) indicating that these events were dependent upon the activation of GABA A Rs (data not shown). As illustrated in Figure 2 A-D, TTXtreated neurons exhibited a significant shift in peak amplitude and frequency compared with controls. Quantifying these observations, the mean amplitude of mIPSCs in TTX-treated neurons was 41.8 Ϯ 3.3 pA (n ϭ 9), significantly lower (Fig. 2 E) ( p Ͻ 0.05) than the value of 50.7 Ϯ 1.9 pA (n ϭ 8) evident in control neurons. In addition, the average frequency of mIPSCs in TTXtreated neurons was 0.5 Ϯ 0.1 Hz (n ϭ 14), significantly lower ( Fig. 2 E) ( p Ͻ 0.05) than values evident in controls (0.9 Ϯ 0.1 Hz; n ϭ 14). However, the 10 -90% rise time and decay time constants were unaltered in neurons treated with TTX compared with control ( Fig. 2 ) (supplemental Fig. 3 , available at www. jneurosci.org as supplemental material). Although alterations in mIPSC amplitude may reflect modified transmitter release or altered channel kinetics, they are also indicative of altered numbers of synaptic receptors. Consistent with decreased mIPSC amplitude, deficits in the number of cell surface ␤3 subunits are also evident in cortical hippocampal neurons treated with TTX as measured via biotinylation ( Fig. 1 ) (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material), suggesting that the cell surface expression levels of GABA A Rs are subject to regulation by the level of neuronal activity.
Chronic changes in neuronal activity regulate the levels of GABA A R ␤3-subunit ubiquitination To further examine the role that activity plays in regulating GABA A R expression levels, we tested the effects of TTX on sub- Neuronal activity regulates the cell surface stability of GABA A Rs. A, Chronic blockade of neuronal activity reduces GABA A Rs expression. Cortical neurons (Ͼ16 DIV) were incubated with or without 2 M TTX for 24 h and then subject to biotinylation with NHS-SS-Biotin. Equal amounts of detergent-soluble protein were added to immobilized avidin and then immunoblotted with anti-␤3 antibody. The cell surface levels of GABA A Rs incorporating ␤3 subunits were measured in control (Con) and assigned a value of 100%. *p Ͻ 0.05, significantly different from control (t test; n ϭ 5). Error bars indicate Ϯ SEM. B, Glutamate receptor antagonists decrease cell surface levels of GABA A Rs. Cortical neurons at 16 DIV were incubated with or without the AMPA receptor antagonist CNQX (10 M) and the NMDA receptor antagonist D-AP-5 (20 M). *p Ͻ 0.05, significantly different from control (t test; n ϭ 5). Error bars indicate Ϯ SEM. C, GABA A R antagonist increase GABA A R cell surface expression levels. Cortical neurons at 16 DIV were treated with 20 M PTX for 24 h, and cell surface ␤3 subunit levels were measured via biotinylation as detailed above. The cell surface levels of GABA A Rs incorporating ␤3 subunits were measured in control and assigned a value of 100%. *p Ͻ 0.05, significantly different from control (t test; n ϭ 6). Error bars indicate Ϯ SEM.
unit ubiquitination. To do so, we immunoprecipitated ␤3 subunits under denaturing conditions and immunoblotted precipitated material with an antibody that recognizes polyubiquitin (FK2). Typical of protein ubiquitination (Haglund et al., 2003b; Haglund and Dikic, 2005) , a smear of immunoreactivity between 66 and 250 kDa was seen with FK2 antibody immunoprecipitating with anti-␤3 but not control IgG (Fig. 3 A, B ). This reaction product represents the addition of multiple 7.6 kDa ubiquitin moieties to various (Ͼ20) lysine residues within the GABA A R ␤3 subunit. By measuring the intensity of the FK2 reaction product between 66 and 250 kDa, it was evident that activity blockade with TTX produced a large (5.0 Ϯ 0.5-fold) increase in the levels of ␤3 subunit ubiquitination (Fig. 3 A, C ) and decreased total cellular levels of the ␤3 subunit. In contrast, treatment of neurons with PTX induced a substantial (3.1 Ϯ 0.3-fold) decrease in the levels of ubiquitinated ␤3 and increased total cellular levels of this receptor subunit (Fig. 3 B, D) .
Polyubiquitination of proteins enhances their targeting to and degradation by the proteasome (Glickman and Ciechanover, 2002) ; thus, we analyzed the role that blocking proteasome activity with epoxomicin (EP) (20 M) has on activity-dependent turnover of GABA A Rs. EP blocked the effects of TTX on cell surface expression levels of GABA A Rs receptors and also significantly increased their cell surface expression levels compared with control (117.5 Ϯ 2.8%) (Fig. 4 A) . Moreover, EP enhanced the level of ␤3 subunit ubiquitination to 250.4 Ϯ 20.8% of control (and significantly increased the cell surface levels of ␤3-containing GABA A Rs by 159.3 Ϯ 8.1% of control levels (Fig.  4 B-D) .
Cell surface GABA A Rs undergo constitutive endocytosis and are eventually targeted for degradation principally in the lysosome . We thus asked whether chronic activity blockade had any influence on the degradation of cell surface GABA A Rs, which reflects their levels of endocytosis, endocytic sorting, and lysozomal degradation. Using biotinylation, it was evident that TTX did not significantly alter the degradation of surface ␤3 subunits (Fig. 4 E) , suggesting that neuronal activity acts principally to regulate GABA A R stability and/or insertion in the secretory pathway. The ubiquitin/␤3 subunit ratios were calculated from neurons exposed to TTX, PTX, or control (Con) neurons as indicated, and the data in control were given a value of 1. *p Ͻ 0.05, significantly different from control (t test; n ϭ 3). Error bars represent Ϯ SEM.
To further test this, we used pulse-chase analysis with [
35 S]methionine after a 24 h incubation period with TTX. This revealed that 89.9 Ϯ 3.5% of newly synthesized ␤3 subunits were still present after the chase period. However, in the presence of TTX, this value was decreased to 35.8 Ϯ 12.4% of that present at time 0 (Fig. 4 F) . To determine whether the observed increased rate of degradation of the ␤3 in the presence of TTX results from increased ER-associated degradation, we performed a pulsechase experiment in the presence of Brefeldin A, an established inhibitor of ER-Golgi transport. Even in the presence of Brefeldin A, turnover of the ␤3 subunit was increased in TTX-treated neurons (supplemental Fig. 4 , available at www.jneurosci.org as supplemental material). Because GABA A R assembly takes place principally in the ER (Connolly et al., 1996; Gorrie et al., 1997) , this decreased stability of newly synthesized receptors in the presence of TTX and Brefeldin A suggest that chronic inactivity acts to principally control receptor stability in the ER.
Identification of major sites for ubiquitination within the GABA A R ␤3 subunit To further examine the role of ubiquitination in regulating GABA A R trafficking, we used mutagenesis to convert all 12 candidate lysine residues for ubiquitination within the major intracellular loop of the ␤3 subunit to arginines in addition to adding the myc epitope at the N terminus of this protein ( M ␤3 K12R ) (supplemental Fig.  5 , available at www.jneurosci.org as supplemental material) (Taylor et al., 2000) . M ␤3
K12R exhibited a large decrease (to 55.4 Ϯ 5.4% of control) (Fig. 5A ) in ubiquitination compared with M ␤3, demonstrating that major sites for this covalent modification reside within the intracellular domain of this GABA A R subunit. Other sites for ubiquitination presumably reside within the transmembrane or extracellular domains of the ␤3 subunit that would be subject to ubiquitination preceding proteasomal degradation (Haglund et al., 2003a ). Consistent with the reduced level of ubiquitination, we observed a significant increase (to 145 Ϯ 4.5% of control) (Fig. 5B) in the cell surface expression levels of M ␤3 K12R compared with M ␤3. To control for possible deleterious effects of the mutations on GABA A R functional expression, we assessed the ability of the M ␤3 K12R subunit to assemble with receptor ␣1 and ␥2 subunits using patchclamp recording in HEK-293 cells (Taylor et al., 2000; Jacob et al., 2005; Bogdanov et al., 2006) . We first assessed the sensitivity of the expressed receptors to benzodiazepine modulation, a property critically dependent on the production of heteromeric ␣1␤3␥2 receptors (Sieghart and Sperk, 2002; Mohler et al., 2005) . Flurazepam (100 nM) produced similar robust enhancements of I GABA of ϳ200% for receptors composed of ␣1␤3␥2 or ␣1␤3 K12R ␥2 subunits (Fig. 5C) (Fig.  5D) . We also examined the effects of MG132 on the maximal currents. For receptors incorporating M ␤3, there was a large and highly significant increase in the magnitude of I GABA using saturating agonist concentrations, an effect that was not replicated for those incorporating M ␤3 K12R subunits (Fig. 5E ). Together, our results demonstrate that major sites for ubiquitination reside within the intracellular domain of the GABA A R ␤3 subunit and that mutation of these residues leads to increased receptor functional expression. They also suggest that these lysine residues within the intracellular domain of the ␤3 subunit play a role in ubiquitin-dependent proteasomal degradation of this subunit. were incubated with or without 20 M EP for 8 h. Cell surface proteins were labeled with NHS-SS-Biotin, isolated with avidin, and immunoblotted with anti-␤3 IgGs. *p Ͻ 0.05, significantly different from control (t test; n ϭ 3). Error bars represent Ϯ SEM. E, Activity blockade does not regulate the degradation of GABA A Rs existing at the cell surface. Cortical neurons (16 DIV) were biotinylated and then incubated at 37°C for 24 h with or without TTX as indicated, whereas neurons at time 0 were lysed and snap frozen. Biotinylated receptors were isolated as in A. ␤3 subunit band intensities were measured, and the levels at time 0 were assigned a value of 100% (n ϭ 3; error bars represent Ϯ SEM). F, Chronic inactivity increases the turnover of GABA A Rs. Neurons at 16 -18 DIV were treated with TTX for 24 h, followed by a pulse chase with [
35 S]methionine. Cultures were lysed and immunoprecipitated with anti-␤3 antibodies or control IgG under denaturing conditions and subject to SDS-PAGE as shown in the top. Band intensities were quantified using a phosphorimager. Data were then normalized to the levels at time 0, which were assigned a value of 100%. *p Ͻ 0.05, significantly different from control at 8 h (t test; n ϭ 3). Error bars represent Ϯ SEM.
Decreasing ␤3 subunit ubiquitination increases receptor accumulation on the neuronal cell surface To examine the relevance of our recombinant studies for GABA A Rs in their native environment, we expressed M ␤3 and M ␤3 K12R subunits in cultured cortical neurons using nucleofection. After immunoprecipitation with rabbit anti-myc antibodies and blotting with FK2 antibody, it was evident that ubiquitination of M ␤3
K12R was decreased to 50.1 Ϯ 4.5% of control (Fig. 6 A) . Consistent with this, the cell surface expression levels of GABA A Rs incorporating M ␤3 K12R subunits were higher than those incorporating M ␤3 subunits (by 141.2 Ϯ 8.2% of control) (Fig.  6 B) . A concern in these experiments is that there is a possible formation of ␤3 homomeric receptors, but it should be noted that this phenomenon was only observed when ␤3 was expressed alone in HEK-293 cells or oocytes (Taylor et al., 1999) . This unique property of ␤3 subunit homomerization is totally suppressed on coexpression with GABA A R ␣ and/or ␥2 subunits. It should also be noted that ␤3 homomers are very unstable with a half-life of 2 h (Wooltorton et al., 1997; Taylor et al., 1999) . Given that neurons express high levels of endogenous GABA A R ␣ and ␥ subunits, the presence of ␤3 homomers is unlikely to be a factor in our experiments.
In principle, the elevated accumulation of receptors incorporating ␤3 K12R on the plasma membrane may reflect changes in either endocytic sorting and/or lysosomal degradation, or in higher rates of insertion from the secretory pathway. Using biotinylation, it was evident that receptors containing M ␤3 and M ␤3 K12R exhibited very similar levels of endocytosis over a 15 min time course (21.3 Ϯ 4.2 vs 20.9 Ϯ 6.2%, respectively) (Fig. 6C) , comparable with levels seen for the endogenous ␤3 subunit . Moreover, cell surface GABA A Rs containing M ␤3 and M ␤3
K12R exhibited very similar rates of degradation over 10 h of 33.5 Ϯ 3.2 and 34.6 Ϯ 3.6%, respectively (Fig. 6 D) . Together, these results suggest that ubiquitination of the ␤3 subunit does not primarily act to regulate the endocytic sorting/lysosomal degradation of GABA A Rs but may act to modulate their insertion, from the secretory pathway, into the plasma membrane.
Ubiquitination of the ␤3 subunit modulates GABA A R insertion into the plasma membrane
To measure the role of ubiquitination in regulating GABA A R membrane insertion, we used ␤3 and ␤3 K12R expression constructs modified at the N terminus with a pHluorin reporter and the minimal BBS. These are termed BBS ␤3 and BBS ␤3 K12R , respectively (Scherf et al., 2001; Katchalski-Katzir et al., 2003; SekineAizawa and Huganir, 2004; Bogdanov et al., 2006) . We previously established that the addition of these reporters to GABA A Rs is functionally silent but allows the selective visualization of cell surface receptor populations in both expression systems and cultured neurons (Jacob et al., 2005; Bogdanov et al., 2006) . These engineered receptors also bind Bgt with high affinity (7.2 ϫ 10 Ϫ9 M) with an off-rate in excess of 5 h, facilitating the analysis of GABA A R insertion in living neurons (Bogdanov et al., 2006) .
We initially characterized the insertion rate of GABA A Rs composed of ␣1 BBS ␤3 in HEK-293 cells by first labeling existing cell surface populations with 10 g/ml Bgt. After extensive washing, cells were labeled with 10 g/ml biotinylated Bgt for varying time periods at 37°C before lysis. Bgt/GABA A R complexes were then isolated with immobilized avidin and immunoblotted with anti-GFP antibodies. A band of ϳ89 kDa representing the BBS ␤3 subunit was evident after 2.5 min incubation at 37°C but not at the time 0 point (Fig. 7A) . This band was not detected in untransfected cells (Fig. 7A) . Its appearance could be blocked by coincubation with 10 g/ml unlabeled Bgt (data not shown). GABA A R insertion appeared to be linear during the first 5 min of incubation before saturating after 20 min (Fig. 7A) . We therefore used a time point of 2.5 min to compare membrane insertion for BBS ␤3 subunits and untransfected controls (UT) were labeled with NHS-SS-Biotin and lysed. Equal amounts of solubilized protein were added to immobilized avidin to isolate biotinylated receptors, which were then subject to immunoblotting with anti-myc IgGs. Cell surface levels were measured, and values were normalized to M ␤3 levels (*p Ͻ 0.05, significantly different from M ␤3, t test; n ϭ 3). C, Benzodiazepine modulation of ␣1 M ␤3␥2 and ␣1 M ␤3 K12R ␥2 receptors. HEK-293 cells expressing GABA A Rs were voltage clamped at Ϫ70 mV. The magnitude of I GABA at 2 M GABA agonist concentration was then measured in the absence (black bars) and presence (gray bars) of 100 nM flurazepam. Normalized conductances in the absence of 100 nM flurazepam were given a value of 1. *p Ͻ 0.05, significantly different from control (unpaired t test; n ϭ 7-9 cells). Error bars represent Ϯ SEM. D, Inhibiting the proteasome does not alter agonist sensitivity of GABA A Rs. Equilibrium GABA concentration-response curves obtained from HEK-293 cells expressing GABA A Rs composed of ␣1 M ␤3 and ␣1 M ␤3 K12R subunits, respectively, in the presence and absence of 20 min pretreatment with 20 M MG132. In each cell, the GABA-activated current was normalized to the conductance evoked by 1000 M GABA. Each point represents the mean Ϯ SEM (n ϭ 6 -8). HEK-293 cells were voltage clamped at Ϫ50 mV holding potential. The curves were generated by the equation g ϭ g max (1/1 ϩ EC 50 / [A] n ), where g and g max represent the conductance induced by a concentration, A, and saturating concentration of GABA, respectively. EC 50 represents the GABA concentration required to evoke half-maximal response, and n H is the Hill slope. E, Inhibiting the activity of the proteasome enhances the maximal current for GABA A Rs containing wild-type ␤3 subunits. HEK-293 cells expressing GABA A Rs composed of ␣1 M ␤3 ( M ␤3) and ␣1 M ␤3 K12R ( M ␤3 K12R ) subunits were exposed to 20 M MG132 for 20 min, and the magnitude of the conductances induced by 1000 M GABA was compared with those in control cells (Con) and those exposed to MG132 (ϩMG132). Typical traces are shown in the left. Data were normalized to the conductances seen in control, which were assigned a value of 100%. *p Ͻ 0.05, significantly different from control (t test; n ϭ 7-9 cells). Error bars represent Ϯ SEM.
and BBS ␤3
K12R , with this time point being given a value of 100%. This revealed that GABA A Rs containing BBS ␤3 K12R subunits exhibited a significantly higher level of insertion (to 141.6 Ϯ 15.8% of control) (Fig. 7B) K12R were incubated with Rd-Bgt to label existing populations of receptors containing BBS binding sites. After washing, neurons were incubated with Alx-Bgt for 5 min at 37°C to label newly inserted receptors. Neurons expressing pH-BBS-tagged GABA A R subunits were identified by their endogenous fluorescence attributable to the presence of the pHluorin reporter in these constructs (Fig. 7C) . Abundant levels of Rd-Bgt labeling were evident only in neurons that also exhibited green fluorescence, and therefore Rd-Bgt staining represents existing cell surface populations of GABA A R at time 0 (Fig. 7C) . Consistent with our observations in HEK-293 cells, newly inserted receptors (Alx-Bgt staining) were evident after 5 min at 37°C (Fig. 7C) . The appearance of these new Bgt binding sites could be totally abolished by coincubation with 20 g/ml unlabeled Bgt (data not shown) (Bogdanov et al., 2006) . Proximal dendrites in acquired images were outlined in MetaMorph to determine the average cell surface fluorescence intensity of newly inserted Alx-Bgtlabeled GABA A Rs along 20 m of a given dendrite. Three dendrites were analyzed per expressing neuron, and at least 15 neurons were examined per construct. By calculating the average fluorescence intensity of Alx-Bgt labeling, it was evident that GABA A Rs incorporating BBS ␤3 K12R subunits exhibited significantly higher levels of insertion compared with those incorporating BBS ␤3 subunits (to134.7 Ϯ 8.6% of control) (Fig. 7D) .
Collectively, these experiments demonstrate that ubiquitination of the GABA A R ␤3 subunit acts to regulate receptor insertion primarily from the secretory pathway.
The effects of neuronal activity on GABA A R cell surface expression levels are mediated via ␤3 subunit ubiquitination We examined whether TTX mediates its effects on GABA A R cell surface stability via modulation of ␤3 subunit ubiquitination. To do so, we measured the insertion of GABA A Rs containing BBS ␤3 and BBS ␤3 K12R subunits into the plasma membranes of hippocampal neurons in the presence or absence of TTX using Bgt binding as outlined above. Interestingly, neurons expressing GABA A Rs incorporating BBS ␤3 subunits appeared to show reduced levels of Alx-Bgt staining after treatment with TTX compared with those containing BBS ␤3 K12R (Fig. 8 A) . Quantifying these data, it was evident that TTX decreased the level of insertion for GABA A Rs containing BBS ␤3 by 34 Ϯ 8% relative to control, but this effect was not replicated for receptors containing pHBBS ␤3 K12R subunits (Fig. 8 B) . Together these results provide a molecular mechanism linking the level of neuronal activity and GABA A R cell surface stability, a mechanism dependent on direct modulation of ␤3 subunit ubiquitination, modified proteasomal degradation, and altered rates of plasma membrane insertion.
Chronic blockade of neuronal activity regulates the accumulation of GABA A Rs containing ␤3 subunits at synaptic sites As a final series of experiments, we measured the effects of modulating the level of GABA A R ubiquitination on their accumulation at synapses. Neurons were transfected with BBS ␤3 or BBS ␤ K12R using nucleofection. At 15 d in vitro, neurons were fixed and immunostained with anti-GFP antibodies and with antibodies against synapsin, an accepted marker for presynaptic terminals, followed by confocal microscopy.
The accumulation of BBS ␤3 and BBS ␤ K12R at synaptic sites was compared using immunofluorescence with an anti-GFP antibody under nonpermeabilized conditions to measure only cell surface receptor populations, followed by anti-synapsin antibodies after permeabilization (Fig. 9A) . The number of synapses containing recombinant ␤3 subunits per unit length of dendrite and their relative intensity were then determined using MetaMorph. From this analysis, it was evident that similar numbers of synapses containing BBS ␤3 and
BBS

␤3
K12R subunits were present on neuronal processes (Fig. 9B) . However, the intensity of the fluorescence signal for synapses containing
BBS
␤3
K12R was significantly higher (126.9 Ϯ 8.4%) compared with synaptic BBS ␤3 subunits (Fig. 9B) . Thus, these results suggest that decreasing GABA A R ubiquitination increases the recep- M ␤3 and M ␤3 K12R subunits were immunoprecipitated (IP) with rabbit anti-myc IgGs, and precipitated material was immunoblotted (IB) with monoclonal anti-ubiquitin (FK2). Blots were then stripped and reprobed with anti-myc IgGs, as indicated. The ratio of UB/␤3 signals was then determined, and values for UB/ M ␤3 (control) were assigned a value of 100%. *p Ͻ 0.05, significantly different from control (t test; n ϭ 4). B, Enhanced cell surface accumulation of GABA A Rs containing M ␤3 K12R subunits. Nucleofected cortical neurons expressing GABA A Rs (5 DIV) incorporating either M ␤3 or M ␤3 K12R subunits were biotinylated with NHS-SS-Biotin and lysed. Equal amounts of solubilized protein were added to immobilized avidin and subjected to immunoblotting with anti-myc IgGs. Band intensities were measured, and the data for M ␤3 were given a value of 100%. *p Ͻ 0.05, significantly different from control (t test; n ϭ 4). Error bars indicate Ϯ SEM. C, GABA A Rs incorporating M ␤3 or M ␤3 K12R subunits show similar levels of endocytosis. Transfected neurons were biotinylated with NHS-SS-Biotin and incubated at 37°C for 15 min to allow endocytosis. Biotinylated proteins were purified on immobilized avidin and immunoblotted with anti-myc IgGs. The level of internalized (In) protein at 15 min was then measured and expressed as a percentage of total cell surface (T) at time 0. Error bars indicate Ϯ SEM (n ϭ 3). D, Cell surface GABA A Rs incorporating M ␤3 or M ␤3 K12R subunits are degraded at a similar rate. Transfected neurons were biotinylated using NHS-SS-Biotin and incubated for 10 h at 37°C. Biotinylated proteins were isolated using immobilized avidin and immunoblotted with anti-myc IgGs, as shown in the top. Band intensities were measured and used to calculate the level of remaining biotinylated M ␤3 or M ␤3 subunits after 10 h incubation at 37°C, with data seen at time 0 being given a value of 100%. Error bars represent Ϯ SEM (n ϭ 3).
tor number at synaptic sites, consistent with their increased cell surface expression levels.
The effects of TTX treatment on the accumulation of GABA A Rs containing recombinant ␤3 subunits at synaptic sites was also ascertained using immunofluorescence (Fig. 9A) . A 24 h, treatment with 2 M TTX significantly decreased the number of synaptic sites containing BBS ␤3 from 17.6 Ϯ 1.9 per 50 m of dendrite in control compared with 8.6 Ϯ 1.1 in the presence of this agent (Fig. 9C ). In contrast, TTX did not significantly alter the number of synapses containing BBS ␤3 K12R subunits (Fig. 9C ). In addition, TTX also reduced the intensity of BBS ␤3 staining at remaining synapses by 31.8 Ϯ 3.5% relative to control, an effect not replicated for synapses containing BBS ␤3 K12R subunits (Fig. 9D ).
Discussion
We have begun to assess the role that chronic changes in neuronal activity play in determining the membrane trafficking and synaptic accumulation of GABA A Rs. We demonstrated that blockade of neuronal depolarization with TTX or the activity of ionotropic glutamate receptors for 24 h decreased the cell surface stability of GABA A Rs receptors containing ␤3, ␣2, or ␥2 subunits; in contrast, enhancing neuronal activity increases the accumulation of these proteins on the neuronal plasma membrane. Therefore, these combined experiments suggest that the level of neuron activity is a powerful determinant of the number of GABA A Rs subtypes containing ␤3, ␣2, or ␥2 on the plasma membrane of cultured cortical and hippocampal neurons. Previous studies on the role that neuronal activity plays in regulating GABA A R cell surface stability have proven controversial. Electrophysiological approaches in mature cultured cortical neurons have shown that chronic inactivity decreases GABA A R number and reduces both frequency and amplitude of miniature inhibitory synaptic currents (Turrigiano et al., 1998; Kilman et al., 2002) . In contrast, blockade of synaptic activity in developing hippocampal neurons does not appear to modify the number of cell surface GABA A Rs or their accumulation at synaptic sites (Harms and Craig, 2005) . This discrepancy may reflect the varying ages of the culture preparations used (Huupponen et al., 2007) or the length of activity blockade, 24 h compared with 18 d. Intriguingly, it has been demonstrated recently that exposure of cultured neurons to TTX over a period of 7-14 d results in retraction of dendrites and a loss of spines (Fishbein and Segal, 2007) . Therefore, this phenomenon may complicate the analysis of the long-term effects of activity blockade on the formation of inhibitory synapses.
In addition to decreasing cell surface expression levels, TTX treatment dramatically enhanced the ubiquitination of the GABA A R ␤3 subunit over the same time course. Accordingly, the ability of TTX to decrease GABA A R cell surface expression levels was dependent on the activity of the proteasome. Interestingly, enhancing neuronal activity by pharmacological blockade of GABA A Rs resulted in decreased receptor ubiquitination and enhanced cell surface expression levels. TTX treatment did not alter receptor endocytosis or cell surface half-life, suggesting that neuronal activity primarily acts to regulate receptor insertion into the plasma membrane from the secretory pathway. Consistent with this, pulse-chase analysis revealed that TTX reduced the stability of newly translated receptor subunits primarily in the ER, the principal subcellular site of GABA A R assembly (Gorrie et al., 1997; Bedford et al., 2001 ). Thus, these results suggest that the level of neuronal activity is a key determinant of GABA A R cell surface stability and strongly suggest that these effects are mediated by altered receptor ubiquitination and proteasomal degradation. Similarly, activity-dependent ubiquitination and degra- BBS ␤3 subunits or untransfected (UT) controls were exposed to 10 g/ml ␣-Bgt to block existing surface receptors. Cells were then washed in PBS before incubation with 10 g/ml biotinylated-Bgt at 37°C for varying time periods, as shown. After lysis, biotinylated Bgt-labeled BBS ␤3 subunits were isolated on immobilized avidin and immunoblotted with anti-GFP antibodies as shown in the top. Band intensities were measured and used to calculate the insertion rate of receptors. Band intensities were normalized to the maximum band intensity at 20 min. T, Total cell surface. B, Enhanced membrane insertion of GABA A Rs containing BBS ␤3 K12R subunits. HEK-293 cells expressing GABA A Rs composed of ␣1 BBS ␤3 or ␣1 BBS ␤3 K12R subunits were treated as outlined in A, and receptor ␤3 subunits were visualized by immunoblotting as shown in the top. These data were then used to compare the levels of receptor insertion at 2.5 min, with data being normalized to the value for BBS ␤3 (control) subunits. *p Ͻ 0.05, significantly different from control (unpaired t test; n ϭ 5). Error bars represent Ϯ SEM. C, Imaging the insertion of GABA A Rs in hippocampal neurons. Neurons (15 DIV) expressing GABA A R BBS ␤3 or BBS ␤3 K12R subunits were labeled at 37°C with 10 g/ml Rd-Bgt for 15 min, washed before incubation with 10 g/ml Alx-Bgt for 5 min at 37°C, and then fixed. Images of pHluorin fluorescence and Rd-Bgt and Alx-Bgt staining, as indicated, were then recorded using confocal microscopy. Boxed areas outlined in image of neurons expressing BBS ␤3 or BBS ␤3 K12R are magnified in panels on the right. Scale bars, 10 m. D, Quantification of cell surface fluorescence intensity of newly inserted Alx-Bgt-labeled GABA A Rs. Data were normalized to values seen in neurons expressing receptor BBS ␤3 subunits (control). *p Ͻ 0.05, significantly different from control (unpaired t test; n ϭ 15). Error bars represent Ϯ SEM. degradation, further highlighting a possible mechanism neurons may use to control GABA A R ubiquitination. In addition to controlling the stability of GABA A Rs, neuronal activity may also regulate the formation of inhibitory synapses at many additional loci, ranging from the stability of cytoskeletal anchors such as gephyrin to the number of innervating presynaptic terminals (Craig et al., 2006) . In summary, our results provide evidence that neuronal activity can regulate the number of cell surface GABA A Rs by modulating their ubiquitination and subsequent proteasomal degradation in the secretory pathway. This process can directly regulate the level of GABA A R insertion into the plasma membrane and their subsequent accumulation at postsynaptic sites. This putative mechanism may therefore play a critical role in coordinating the level of local synaptic activity in the brain and thus contribute to homeostatic synaptic plasticity. K12R subunits treated with or without TTX (2 M) for 24 h, as indicated. Neurons were fixed and stained with rabbit anti-GFP IgGs and Texas Redconjugated anti-rabbit IgGs. Neurons were then permeabilized and stained with monoclonal anti-synapsin IgGs and Cy5-conjugated anti-mouse IgGs (synapsin staining was assigned the color green). Panels on the right in each image represent enlargements of the boxed areas outlined in the left panels, and arrows indicate synaptic sites containing BBS ␤3 or BBS ␤3 K12R . Scale bars, 10 m. B, Quantification of the number of BBS ␤3 and BBS ␤3 K12R synaptic sites and their fluorescence intensity. Synaptic sites were defined by the colocalization of anti-GFP staining with synapsin staining for GABA A Rs incorporating either BBS ␤3 or BBS ␤3 K12R subunits. *p Ͻ 0.05, significantly different from BBS ␤3 (unpaired t test; n ϭ 20 neurons). C, Quantification of the number of BBS ␤3 and BBS ␤3 K12R synaptic sites after incubation with (gray bars) or without (black bars) TTX (*p Ͻ 0.05, significantly different from control, t test; n ϭ 15-20 neurons). D, Quantification of BBS ␤3 and BBS ␤3 K12R subunit fluorescence intensity at synaptic sites. The intensity of Texas Red fluorescence colocalizing with 0.5-2 m areas containing synapsin staining were determined for neurons expressing BBS ␤3 or BBS ␤3 K12R subunits under control conditions (black bars) or after treatment with TTX (black bars). Average fluorescence intensity data in control neurons were assigned a value of 100% (black bars). *p Ͻ 0.05, significantly different from control (t test; n ϭ 15-20 neurons). Error bars throughout represent Ϯ SEM. Con, Control.
